The number of players affected by the new anti-prozac drug is expected to grow, with a potential surge in new cases in the weeks to come.
According to Dr. Giuseppe De Rosa, the head of the PASADENA drug project, up to 4,000 patients in Italy are at risk of losing their hair due to the medication, and another 3,000 are at high risk due to other drugs.
He also said the drug will be prescribed to more than 100,000 people in the United States.
“I think the number will increase, especially among young people,” De Rosa told Sky Italia.
The World Health Organization estimates the new drug will save people’s hair in excess of 10,000 times in a year.
Dr. De Rosa said the increased cases were a sign of the increased need to address the drug’s side effects.
“In many people, they are suffering from the side effects of this drug, such as depression, anxiety and the like,” he said.
With the drug only being prescribed for certain diseases and conditions, the likelihood of the new cases becoming serious is slim.
Despite the heightened pressure to tackle the drug, the number of new cases could be in the tens of thousands by the end of the year, said De Rosa.
As of January 25, the Italian authorities reported the first 2,000 new cases.
The International Federation of the Hair Loss Association said it was concerned about the number and type of new infections.
“The trend in new infections has been increasing.
I think it is going to be worse in the coming months,” the association’s president Stefano Giuseppini told La Repubblica.
Meanwhile, a study published in the Journal of the American Academy of Dermatology found that up to one-third of patients who started taking the drug in 2012 started getting it again in 2016.
More than 80 percent of those patients were already taking the anti-depressant medication Prozac, the study found.
Possible complications of Prozac include: •Anxiety, depression and agitation